Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

MAPKAPK2 (MK2), the direct substrate of p38 MAPK, has been well-acknowledged as an attractive drug target for cancer therapy. However, few studies have assessed the functions of it in multiple myeloma (MM). In the present study, MK2 expression of MM patients was analyzed by gene expression profiling...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Principais autores: Guo, Mengjie, Sun, Dongdong, Fan, Zhimin, Yuan, Yuxia, Shao, Miaomiao, Hou, Jianhao, Zhu, Yuqi, Wei, Rongfang, Zhu, Yan, Qian, Jinjun, Li, Fei, Yang, Ye, Gu, Chunyan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694709/
https://ncbi.nlm.nih.gov/pubmed/31440466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados